February 10th, 2022
Alkem licenses technology from Harvard University, aiming to treat ischemic injury and vascular diseases
Novel delivery of established growth and neurotropic factors enables local, sustained release for greater efficacy
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Bioengineering
August 20th, 2021
Harvard’s eardrum-restoring PhonoGraft enters commercial development
3D-printed graft developed by researchers at Harvard’s Wyss Institute, Harvard SEAS, and Mass Eye and Ear to be commercialized by Desktop Health, following the startup’s acquisition
June 2nd, 2021
Harvard licenses technology to Obatala Sciences to advance discovery in obesity, diabetes, and cancer
Development by New Orleans biotech company to enable studies of human fat tissue in vitro
July 22nd, 2020
A versatile vessel for next-gen therapeutics
Harvard’s ARMMs technology to be commercialized by Vesigen Therapeutics for targeted intracellular delivery of large-molecule drugs
July 21st, 2020
Tough gel technology licensed to Amend Surgical for oral surgery applications
Medical device company will pursue development of strong, biocompatible adhesive that could replace sutures and dental membranes
